Faculty Information |
|
Article types | Original article |
Language | English |
Refereed paper | Not refereed |
Title | Preplanned safety analysis of the JFMC37-0801 trial: A randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stageIII colon cancer. |
Journal | Formal name:The International Journal of Clinical Oncology |
Publisher | Springer |
Volume, Number, Page | 22(3),pp.494-504 |
Papers・Author | Suto Takeshi, Ishiguro Megumi, Hamada Chikuma, Kunieda Katsuyuki, Masuko Hiroyuki, Kondo Ken, Ishida Hideyuki, Nishimura Genichi, Sasaki Kazuaki, Morita Takuyuki, Hazama Shoichi, Maeda Koutarou, Mishima Hideyuki, Ike Hideyuki, Sadahiro Sotaro, Sugihara Kenichi, Okajima Masazumi, Saji Shigetoyo, Sakamoto Junichi, Tomita Naohiro |
Publication date | 2017/06 |